Methylprednisolone or naloxone treatment after acute spinal cord injury

1-year follow-up data: Results of the second National Acute Spinal Cord Injury Study

M. B. Bracken, M. J. Shepard, W. F. Collins, T. R. Holford, D. S. Baskin, H. M. Eisenberg, Eugene S. Flamm, L. Leo-Summers, J. C. Maroon, L. F. Marshall, P. L. Perot, J. Piepmeier, V. K H Sonntag, F. C. Wagner, J. L. Wilberger, H. R. Winn, W. Young

Research output: Contribution to journalArticle

579 Citations (Scopus)

Abstract

The 1-year follow-up data of a multicenter randomized controlled trial of methylprednisolone (30 mg/kg bolus and 5.4 mg/kg/hr for 23 hours) or naloxone (5.4 mg/kg bolus and 4.0 mg/kg/hr for 23 hours) treatment for acute spinal cord injury are reported and compared with placebo results. In patients treated with methylprednisolone within 8 hours of injury, increased recovery of neurological function was seen at 6 weeks and at 6 months and continued to be observed 1 year after injury. For motor function, this difference was statistically significant (p = 0.030), and was found in patients with total sensory and motor loss in the emergency room (p = 0.019) and in those with some preservation of motor and sensory function (p = 0.024). Naloxone-treated patients did not show significantly greater recovery. Patients treated after 8 hours of injury recovered less motor function if receiving methylprednisolone (p = 0.08) or naloxone (p = 0.10) as compared with those given placebo. Complication and mortality rates were similar in either group of treated patients as compared with the placebo group. The authors conclude that treatment with the study dose of methylprednisolone is indicated for acute spinal cord trauma, but only if it can be started within 8 hours of injury.

Original languageEnglish (US)
Pages (from-to)23-31
Number of pages9
JournalJournal of Neurosurgery
Volume76
Issue number1
StatePublished - 1992
Externally publishedYes

Fingerprint

Methylprednisolone
Naloxone
Spinal Cord Injuries
Placebos
Wounds and Injuries
Therapeutics
Recovery of Function
Hospital Emergency Service
Randomized Controlled Trials
Mortality

Keywords

  • acute spinal cord injury
  • methylprednisolone
  • naloxone
  • randomized clinical trial

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Bracken, M. B., Shepard, M. J., Collins, W. F., Holford, T. R., Baskin, D. S., Eisenberg, H. M., ... Young, W. (1992). Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data: Results of the second National Acute Spinal Cord Injury Study. Journal of Neurosurgery, 76(1), 23-31.

Methylprednisolone or naloxone treatment after acute spinal cord injury : 1-year follow-up data: Results of the second National Acute Spinal Cord Injury Study. / Bracken, M. B.; Shepard, M. J.; Collins, W. F.; Holford, T. R.; Baskin, D. S.; Eisenberg, H. M.; Flamm, Eugene S.; Leo-Summers, L.; Maroon, J. C.; Marshall, L. F.; Perot, P. L.; Piepmeier, J.; Sonntag, V. K H; Wagner, F. C.; Wilberger, J. L.; Winn, H. R.; Young, W.

In: Journal of Neurosurgery, Vol. 76, No. 1, 1992, p. 23-31.

Research output: Contribution to journalArticle

Bracken, MB, Shepard, MJ, Collins, WF, Holford, TR, Baskin, DS, Eisenberg, HM, Flamm, ES, Leo-Summers, L, Maroon, JC, Marshall, LF, Perot, PL, Piepmeier, J, Sonntag, VKH, Wagner, FC, Wilberger, JL, Winn, HR & Young, W 1992, 'Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data: Results of the second National Acute Spinal Cord Injury Study', Journal of Neurosurgery, vol. 76, no. 1, pp. 23-31.
Bracken, M. B. ; Shepard, M. J. ; Collins, W. F. ; Holford, T. R. ; Baskin, D. S. ; Eisenberg, H. M. ; Flamm, Eugene S. ; Leo-Summers, L. ; Maroon, J. C. ; Marshall, L. F. ; Perot, P. L. ; Piepmeier, J. ; Sonntag, V. K H ; Wagner, F. C. ; Wilberger, J. L. ; Winn, H. R. ; Young, W. / Methylprednisolone or naloxone treatment after acute spinal cord injury : 1-year follow-up data: Results of the second National Acute Spinal Cord Injury Study. In: Journal of Neurosurgery. 1992 ; Vol. 76, No. 1. pp. 23-31.
@article{c824056def854c87b5b7e6b2106edceb,
title = "Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data: Results of the second National Acute Spinal Cord Injury Study",
abstract = "The 1-year follow-up data of a multicenter randomized controlled trial of methylprednisolone (30 mg/kg bolus and 5.4 mg/kg/hr for 23 hours) or naloxone (5.4 mg/kg bolus and 4.0 mg/kg/hr for 23 hours) treatment for acute spinal cord injury are reported and compared with placebo results. In patients treated with methylprednisolone within 8 hours of injury, increased recovery of neurological function was seen at 6 weeks and at 6 months and continued to be observed 1 year after injury. For motor function, this difference was statistically significant (p = 0.030), and was found in patients with total sensory and motor loss in the emergency room (p = 0.019) and in those with some preservation of motor and sensory function (p = 0.024). Naloxone-treated patients did not show significantly greater recovery. Patients treated after 8 hours of injury recovered less motor function if receiving methylprednisolone (p = 0.08) or naloxone (p = 0.10) as compared with those given placebo. Complication and mortality rates were similar in either group of treated patients as compared with the placebo group. The authors conclude that treatment with the study dose of methylprednisolone is indicated for acute spinal cord trauma, but only if it can be started within 8 hours of injury.",
keywords = "acute spinal cord injury, methylprednisolone, naloxone, randomized clinical trial",
author = "Bracken, {M. B.} and Shepard, {M. J.} and Collins, {W. F.} and Holford, {T. R.} and Baskin, {D. S.} and Eisenberg, {H. M.} and Flamm, {Eugene S.} and L. Leo-Summers and Maroon, {J. C.} and Marshall, {L. F.} and Perot, {P. L.} and J. Piepmeier and Sonntag, {V. K H} and Wagner, {F. C.} and Wilberger, {J. L.} and Winn, {H. R.} and W. Young",
year = "1992",
language = "English (US)",
volume = "76",
pages = "23--31",
journal = "Journal of Neurosurgery",
issn = "0022-3085",
publisher = "American Association of Neurological Surgeons",
number = "1",

}

TY - JOUR

T1 - Methylprednisolone or naloxone treatment after acute spinal cord injury

T2 - 1-year follow-up data: Results of the second National Acute Spinal Cord Injury Study

AU - Bracken, M. B.

AU - Shepard, M. J.

AU - Collins, W. F.

AU - Holford, T. R.

AU - Baskin, D. S.

AU - Eisenberg, H. M.

AU - Flamm, Eugene S.

AU - Leo-Summers, L.

AU - Maroon, J. C.

AU - Marshall, L. F.

AU - Perot, P. L.

AU - Piepmeier, J.

AU - Sonntag, V. K H

AU - Wagner, F. C.

AU - Wilberger, J. L.

AU - Winn, H. R.

AU - Young, W.

PY - 1992

Y1 - 1992

N2 - The 1-year follow-up data of a multicenter randomized controlled trial of methylprednisolone (30 mg/kg bolus and 5.4 mg/kg/hr for 23 hours) or naloxone (5.4 mg/kg bolus and 4.0 mg/kg/hr for 23 hours) treatment for acute spinal cord injury are reported and compared with placebo results. In patients treated with methylprednisolone within 8 hours of injury, increased recovery of neurological function was seen at 6 weeks and at 6 months and continued to be observed 1 year after injury. For motor function, this difference was statistically significant (p = 0.030), and was found in patients with total sensory and motor loss in the emergency room (p = 0.019) and in those with some preservation of motor and sensory function (p = 0.024). Naloxone-treated patients did not show significantly greater recovery. Patients treated after 8 hours of injury recovered less motor function if receiving methylprednisolone (p = 0.08) or naloxone (p = 0.10) as compared with those given placebo. Complication and mortality rates were similar in either group of treated patients as compared with the placebo group. The authors conclude that treatment with the study dose of methylprednisolone is indicated for acute spinal cord trauma, but only if it can be started within 8 hours of injury.

AB - The 1-year follow-up data of a multicenter randomized controlled trial of methylprednisolone (30 mg/kg bolus and 5.4 mg/kg/hr for 23 hours) or naloxone (5.4 mg/kg bolus and 4.0 mg/kg/hr for 23 hours) treatment for acute spinal cord injury are reported and compared with placebo results. In patients treated with methylprednisolone within 8 hours of injury, increased recovery of neurological function was seen at 6 weeks and at 6 months and continued to be observed 1 year after injury. For motor function, this difference was statistically significant (p = 0.030), and was found in patients with total sensory and motor loss in the emergency room (p = 0.019) and in those with some preservation of motor and sensory function (p = 0.024). Naloxone-treated patients did not show significantly greater recovery. Patients treated after 8 hours of injury recovered less motor function if receiving methylprednisolone (p = 0.08) or naloxone (p = 0.10) as compared with those given placebo. Complication and mortality rates were similar in either group of treated patients as compared with the placebo group. The authors conclude that treatment with the study dose of methylprednisolone is indicated for acute spinal cord trauma, but only if it can be started within 8 hours of injury.

KW - acute spinal cord injury

KW - methylprednisolone

KW - naloxone

KW - randomized clinical trial

UR - http://www.scopus.com/inward/record.url?scp=0026601887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026601887&partnerID=8YFLogxK

M3 - Article

VL - 76

SP - 23

EP - 31

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

SN - 0022-3085

IS - 1

ER -